Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Date:5/2/2013

tigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design and statements regarding the potential benefits and potential development of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product candidates and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

ORCA™, Borealis-1™, Borealis-2™, Spruce™, Rainier™ and Pacific™, are registered trademarks of OncoGenex Pharmaceuticals, Inc.
ABRAXANE® is a registered trademark of Celgene Corporation
JEVTANA® is a registered trademark of sanofi-aventis
Zytiga® is a registered trademark of the Johnson & Johnson Corporation

 


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
2. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
3. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
4. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
6. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
7. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
8. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
9. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
10. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
11. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015 The Economist Events, 21 st ... last week on 26 February was host to some of the ... of topical issues facing the sector. This year,s theme, , ... ra , , observed the challenges the industry is facing ... Panel speakers offered contrasting and thought-provoking commentary on how to deal ...
(Date:3/2/2015)... Abbott , Abbott Diabetes Care, American ... Animas Corp., Apple, Arkray, Asante Solutions, A. ... BioSense, CareFusion, Carewell Biotech, Centres for Medicare ... ), Center for Disease Control and Prevention ... CFR Pharmaceuticals, Chugai, Conceptus, Covidien, Cygnus, ConvaTec, ...
(Date:3/1/2015)... 2015  USPlabs has notified the Food and ... that media reports saying that a company product ... February 28, 2015, the Center for Drug Evaluation ... the contamination of a dietary supplement product labeled ... as "OEP") with a prescription drug active ingredient, ...
Breaking Medicine Technology:21 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 221 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 321 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 421 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 521 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 6Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2OEP Product Is Counterfeit 2
... Dynamics International, Inc. (CDI) today announced an agreement with ... iCell® Cardiomyocytes , the first commercially available product based on ... This distribution agreement brings the vision of the two pioneers ... Dr. Shinya Yamanaka , a step closer to making the ...
... Reportlinker.com announces that a new market research ... Asia-Pacific Dental Devices Market Outlook ... Asia-Pacific Dental Devices Market ... GlobalData,s new report, "Asia-Pacific ...
Cached Medicine Technology:iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 2iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 3Asia-Pacific Dental Devices Market Outlook to 2016 2Asia-Pacific Dental Devices Market Outlook to 2016 3
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
(Date:3/1/2015)... As residents and business owners in Southlake, ... Carita Weaver, believe in supporting local organizations and ... Chamber of Commerce, Carroll Independent School District and ... website for Southlake mayoral candidate Laura Hill: ... Hill’s campaign, the website combines images, videos and ...
(Date:3/1/2015)... March 01, 2015 Adults who are ... rates for term or universal policies can now use ... the best life insurance companies for single adults can ... at http://quotespros.com/life-insurance.html . , The rate plans that ... are tied to a number of life protection policies. ...
(Date:3/1/2015)... York, NY (PRWEB) March 01, 2015 ... has grown substantially over the past few weeks in ... LLP are actively filing claims, the Firm announces. ... reflects 7,713 cases in the Bergen County proceeding established ... Inc., compared with a few weeks earlier, when 90 ...
(Date:3/1/2015)... 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled Transccordion. ... to any FCPX editors project.” Said Christiana Austin, CEO ... tools needed to easily drag and drop their accordion ... many different controls over the parameters of this transition ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... N.J., April 1, 2008 Defined Health has,announced ... for its 8th,annual Therapeutic Insight conference. Therapeutic Insight ... 30, 2008, at The Westin New York at ... registration information,along with content and attendee statistics from ...
... Association of,Health Plans (OAHP), the statewide trade association of ... Ohioans, announced the,election of new officers this week., ... chair of OAHP.,Crampton is the Chair of the Board ... serving the Ohio CFC Medicaid program in,the Northwest and ...
... 1, 2008 Core People Resources,today announced a ... Wexford, PA. CCSC provides options in healthcare coverage ... chamber members through,its ChamberChoice portfolio., The partnership ... level of employer services, including comprehensive human resource,outsourcing ...
... 2008 Leading consumer,employer and labor organizations ... physician groups and health insurers on principles,to ... and report the,information to consumers., The ... Tiering Programs" announced today creates a national ...
... Turns Assets from Retirement Plans Into Guaranteed Income ... ... NEW YORK, April 1, 2008 AXA Equitable Life,Insurance ... new variable annuity -- Crossings(SM): My Lifetime,IRA(SM), designed specifically as ...
... Acomplia might help fight coronary disease , , TUESDAY, April 1 ... not help slow atherosclerosis, a buildup of arterial plaque that,s ... trial did not find any evidence that the drug actually ... one measure of plaque build-up in arteries. , Acomplia ...
Cached Medicine News:Health News:Shannon Brownlee, Author of 'Overtreated,' to Keynote at Defined Health's 8th Annual Therapeutic Insight Conference 2Health News:Ohio Association of Health Plans Announces New Officers 2Health News:Core People Partners to Expand Services 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 4Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 2Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: